Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
From repeated measures analysis model: Change = baseline + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
From repeated measures analysis model: Change = baseline + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
From repeated measures analysis model: Change = baseline + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Normalized atheroma volume is defined as mean atheroma area x median segment length in cohort. Model Adjusted Change = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior Oral Anti-Hyperglycemic Diabetic Medications(s) (OAD). (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same 10 mm segment of non-intervened coronary arteries with the greatest degree of atheroma volume at Baseline, from Baseline to Month 18, including the nominal change in atheroma volume and atheroma area. Model Adjusted Change = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same 10 mm segment of non-intervened coronary arteries with the greatest degree of atheroma volume at Baseline, from Baseline to Month 18, including the nominal change in atheroma volume and atheroma area. Model Adjusted Change = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18
From repeated measures analysis model: Change = Baseline + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
From repeated measures analysis model: Change = Baseline + visit + sex + region + treatment + prior Oral Anti-Hyperglycemic Diabetic Medications(s) (OAD) + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
This was 1 of 2 MACE composite endpoints and was a secondary efficacy endpoint. (NCT00116831)
Timeframe: Baseline to Month 21
This was 1 of 2 MACE composite endpoints and was a secondary efficacy endpoint. (NCT00116831)
Timeframe: Baseline to Month 21
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18 (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18 (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Normalized atheroma volume is defined as mean atheroma area x median segment length in cohort. (NCT00116831)
Timeframe: Baseline to Month 18
The primary efficacy endpoint was change in PAV (defined as total atheroma volume divided by total vessel volume x 100) within a 40 mm segment in non-intervened coronary arteries from Baseline to Month 18, based upon Intravascular Ultrasound (IVUS) assessment. (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same 10 mm segment of non-intervened coronary arteries with the greatest degree of atheroma volume at Baseline, from Baseline to Month 18, including the nominal change in atheroma volume and atheroma area (NCT00116831)
Timeframe: Baseline to Month 18
IVUS-derived endpoints measured within the same 10 mm segment of non-intervened coronary arteries with the greatest degree of atheroma volume at Baseline, from Baseline to Month 18, including the nominal change in atheroma volume and atheroma area (NCT00116831)
Timeframe: Baseline to Month 18
It was measured as ratio to baseline as percentage change based on log-transformed data : 100 x (exp(Mean change on log scale) - 1). Model Adjusted change based on ANCOVA: Log(value) - log(Baseline) = log(Baseline) + sex + region + treatment + prior OAD + cardiac procedure. (NCT00116831)
Timeframe: Baseline to Month 18
Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
It was measured as ratio to baseline as percentage change based on log-transformed data : 100 x (exp(Mean change on log scale) - 1)It was measured as ratio to baseline as percentage change based on log-transformed data : 100 x (exp(Mean change on log scale) - 1). Ratio to baseline as %change mean (%) was used as the estimation parameter for both groups. (NCT00116831)
Timeframe: Baseline to Month 18
Changes in cardiovascular biomarkers from Baseline to Month 18, such as high sensitivity C-reactive protein (hsCRP) . Repeated measures analysis model: Log(value) - log(baseline) = log(baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
Changes in cardiovascular biomarkers from Baseline to Month 18, such as matrix metalloproteinase-9 (MMP-9). Repeated measures analysis model: Log(value) - log(baseline) = log(baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18
A measure of the change in fasting plasma glucagon from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks
Change in blood glucose level measured over a 3 month period from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks
All subjects received a Double-Tracer Oral Glucose Tolerance Test (OGTT) with 75g of glucose containing 14C-glucose together with intravenous primed-continuous infusion of 3(3H)-glucose for 240 minutes, at baseline (prior to) and after 16 weeks of therapy. Blood and urine samples were obtained during the OGTT to determine EGP. (NCT02613897)
Timeframe: Baseline and 16 weeks
Number of participants taking Angiotensin-converting enzyme (ACE Inhibitor) or Angiotensin-receptor blocker (ARB) at 12 months (NCT00432809)
Timeframe: 1 year
Change in glycated hemoglobin(HbA1c)from baseline in percentage points / percent change (NCT00432809)
Timeframe: 1 year - baseline
Median percent change in high-sensitivity C-reactive protein (hs-CRP)from baseline at 12 months (NCT00432809)
Timeframe: 1 year
Mean glycated hemoglobin (HbA1c) at 12 months for each of the 3 groups, in percentage points (NCT00432809)
Timeframe: 1 year
The proportion of subjects with a glycated hemoglobin level of 6% or less(without diabetes medications) 12 months after randomization. (NCT00432809)
Timeframe: 1 year
The proportion of subjects with a glycated hemoglobin level of 6% or less(with or without diabetes medications) 12 months after randomization (baseline measure). (NCT00432809)
Timeframe: 1 year
Article | Year |
Lipid profiling reveals different therapeutic effects of metformin and glipizide in patients with type 2 diabetes and coronary artery disease.Diabetes care, 2014, Volume: 37, Issue:10
Topics: Aged; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Doub | 2014 |
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics.American heart journal, 2008, Volume: 156, Issue:6
Topics: Adult; Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Prog | 2008 |
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History).The international journal of cardiovascular imaging, 2012, Volume: 28, Issue:3
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Coronary Angio | 2012 |
Drug-induced reversal of early diabetic microangiopathy.The New England journal of medicine, 1983, Dec-22, Volume: 309, Issue:25
Topics: Adult; Basement Membrane; Blood Glucose; Capillaries; Diabetic Angiopathies; Female; Glipizide; Gluc | 1983 |
Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.Diabetes care, 1995, Volume: 18, Issue:8
Topics: Aged; Albuminuria; Animals; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Blood Pressure | 1995 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM)Diabetes care, 1992, Volume: 15, Issue:11
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; F | 1992 |
Enzyme activities as a predictor of diabetic vasculopathy.The American journal of medicine, 1986, Volume: 80, Issue:4
Topics: Acetylglucosaminidase; Adult; Basement Membrane; Capillaries; Diabetic Angiopathies; Female; Glipizi | 1986 |
Delay of progression of diabetic microangiopathy.Metabolism: clinical and experimental, 1988, Volume: 37, Issue:2 Suppl 1
Topics: Acetylglucosaminidase; Adult; Basement Membrane; Blood Glucose; Diabetic Angiopathies; Glipizide; Gl | 1988 |